Abstract
Placenta plays a crucial role in the development of the fetus. By connecting the fetus to the maternal circulation, it allows provision of oxygen and nutrients to the fetus while removing carbon dioxide and metabolic wastes. The placenta also provides essential hormones for the pregnancy and enables immunological protection for the fetus against infection and rejection by the maternal immune system. In this chapter, pathology of abortions as well as gestational trophoblastic diseases is discussed. Gestational trophoblastic diseases encompass a family of aggressive neoplasms, nonneoplastic lesions, and lesions with malignant potential that arise from various types of placental trophoblasts and may pose challenging problems in differential diagnoses in daily pathology practice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Moore KL, Persaud TVN, Torchia MG. Before we are born : essentials of embryology and birth defects. Philadelphia, PA: Elsevier/Saunders; 2016.
Paradinas FJ, Elston CW. Gestational trophoblastic diseases. In: Fox H, Wells M, editors. Haines & Taylor obstetrical and gynaecological pathology. Edinburgh: Churchill Livingstone; 2003. p. 1359–430.
Shih IM, Mazur MT, Kurman RJ. Gestational trophoblastic disease and related lesions. In: Kurman R, editor. Blaustein’s pathology of the female genital tract. New York: Springer Verlag; 2002.
Cheung A. Gestational trophoblastic disease. In: Robboy S, Mutter G, Prat J, Bentley R, Russell P, Anderson M, editors. Robboy’s pathology of the female reproductive tract. China: Elsevier Churchill Livingstone; 2009. p. 881–907.
Lage JM. Gestational trophoblastic diseases. In: Robbey S, Russel R, editors. Pathology of the female reproductive tract. London: Elsevier; 2001.
Lee CQ, Gardner L, Turco M, Zhao N, Murray MJ, Coleman N, Rossant J, Hemberger M, Moffett A. What is trophoblast? A combination of criteria define human first-trimester trophoblast. Stem Cell Rep. 2016;6:257–72. https://doi.org/10.1016/j.stemcr.2016.01.006.
Mittal K, Soslow R, McCluggage WG. Application of immunohistochemistry to gynecologic pathology. Arch Pathol Lab Med. 2008;132:402–23. https://doi.org/10.1043/1543-2165(2008)132[402:aoitgp]2.0.co;2.
Xue WC, Khoo US, Ngan HY, Chan KY, Ip PP, Tsao SW, Cheung AN. c-mos immunoreactivity aids in the diagnosis of gestational trophoblastic lesions. Int J Gynecol Pathol. 2004;23:145–50.
Zhang HJ, Xue WC, Siu MK, Liao XY, Ngan HY, Cheung AN. P63 expression in gestational trophoblastic disease: correlation with proliferation and apoptotic dynamics. Int J Gynecol Pathol. 2009;28(2):172–8. https://doi.org/10.1097/PGP.0b013e318189555b.
Singer G, Kurman RJ, McMaster MT, Shih Ie M. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol. 2002;26:914–20.
Shih IM, Nesbit M, Herlyn M, Kurman RJ. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. Mod Pathol. 1998;11:1098–106.
Mao TL, Kurman RJ, Jeng YM, Huang W, Shih Ie M. HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Am J Surg Pathol. 2008;32:236–42. https://doi.org/10.1097/PAS.0b013e31812e0046.
Shih Ie M. Trophogram, an immunohistochemistry-based algorithmic approach, in the differential diagnosis of trophoblastic tumors and tumorlike lesions. Ann Diagn Pathol. 2007;11:228–34. https://doi.org/10.1016/j.anndiagpath.2007.04.001.
Xue WC, Cheung AN. Complications of early pregnancy, including trophoblastic neoplasia. In: Zheng W, editor. Pathology of obstetrics and gynaecology; 2010.
Royal College of Obstetricians and Gynecologists (2011) The investigation and treatment of couples with recurrent first trimester and second-trimester miscarriage. Green-top Guideline No. 17.
Messaed C, Chebaro W, Di Roberto RB, Rittore C, Cheung A, Arseneau J, Schneider A, Chen MF, Bernishke K, Surti U, Hoffner L, Sauthier P, Buckett W, Qian J, Lau NM, Bagga R, Engert JC, Coullin P, Touitou I, Slim R. NLRP7 in the spectrum of reproductive wastage: rare non-synonymous variants confer genetic susceptibility to recurrent reproductive wastage. J Med Genet. 2011;48:540–8. https://doi.org/10.1136/jmg.2011.089144.
Slim R, Ao A, Surti U, Zhang L, Hoffner L, Arseneau J, Cheung A, Chebaro W, Wischmeijer A. Recurrent triploid and dispermic conceptions in patients with NLRP7 mutations. Placenta. 2011;32:409–12. https://doi.org/10.1016/j.placenta.2011.02.001.
Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R, Bagga R, Kircheisen R, Ao A, Ratti B, Hanash S, Rouleau GA, Slim R. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet. 2006;38:300–2. https://doi.org/10.1038/ng1740.
Bouyer J, Coste J, Shojaei T, Pouly JL, Fernandez H, Gerbaud L, Job-Spira N. Risk factors for ectopic pregnancy: a comprehensive analysis based on a large case-control, population-based study in France. Am J Epidemiol. 2003;157:185–94.
Fernandez H, Gervaise A. Ectopic pregnancies after infertility treatment: modern diagnosis and therapeutic strategy. Hum Reprod Update. 2004;10:503–13. https://doi.org/10.1093/humupd/dmh043.
Zhang Y, Chen J, Lu W, Li B, Du G, Wan X. Clinical characteristics of persistent ectopic pregnancy after salpingostomy and influence on ongoing pregnancy. J Obstet Gynaecol Res. 2017;43:564–70. https://doi.org/10.1111/jog.13251.
Burton JL, Lidbury EA, Gillespie AM, Tidy JA, Smith O, Lawry J, Hancock BW, Wells M. Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancy. Histopathology. 2001;38:409–17.
Sebire NJ, Lindsay I, Fisher RA, Savage P, Seckl MJ. Overdiagnosis of complete and partial hydatidiform mole in tubal ectopic pregnancies. Int J Gynecol Pathol. 2005;24:260–4.
Hui P, Baergen RN, Cheung AN, Fukunaga M, Gersell DJ, Lage JM, Ronnett BM, Sebire NJ, Wells M. Gestational trophoblastic disease. In: Kurman RJ, Young RH, Carcangiu ML, Herrington S, editors. In: WHO classification of tumours of female reproductive organs. 4th ed. Lyon: IARC; 2014. p. 155.
Clement P, Young R. Trophoblastic lesions, miscellaneous primary uterine neoplasms, hematopoietic neoplasms, and metastatic neoplasms to the uterus. In: Clement P, Young R, editors. Atlas of gynecologic surgical pathology. 3rd ed. Philadelphia: Saunders; 2013.
Ngan HY, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR. Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet. 2015;131(Suppl 2):S123–6. https://doi.org/10.1016/j.ijgo.2015.06.008.
Atrash HK, Hogue CJ, Grimes DA. Epidemiology of hydatidiform mole during early gestation. Am J Obstet Gynecol. 1986;154:906–9.
Bagshawe KD, Dent J, Webb J. Hydatidiform mole in England and Wales 1973–83. Lancet. 1986;2:673–7.
Buckley JD. The epidemiology of molar pregnancy and choriocarcinoma. Clin Obstet Gynecol. 1984;27:153–9.
Hayashi K, Bracken MB, Freeman DH Jr, Hellenbrand K. Hydatidiform mole in the United States (1970–1977): a statistical and theoretical analysis. Am J Epidemiol. 1982;115:67–77.
Ngan HY, Kohorn EI, Cole LA, Kurman RJ, Kim SJ, Lurain JR, Seckl MJ, Sasaki S, Soper JT. Trophoblastic disease. Int J Gynaecol Obstet. 2012;119(Suppl 2):S130–6. https://doi.org/10.1016/S0020-7292(12)60026-5.
Ngan HY, Tam KF, Lam KW, Chan KK. Relapsed gestational trophoblastic neoplasia: a 20-year experience. J Reprod Med. 2006;51:829–34.
Hando T, Ohno M, Kurose T. Recent aspects of gestational trophoblastic disease in Japan. Int J Gynaecol Obstet. 1998;60(Suppl 1):S71–6.
Kim JH, Park DC, Bae SN, Namkoong SE, Kim SJ. Subsequent reproductive experience after treatment for gestational trophoblastic disease. Gynecol Oncol. 1998;71:108–12. https://doi.org/10.1006/gyno.1998.5167.
Altieri A, Franceschi S, Ferlay J, Smith J, La Vecchia C. Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol. 2003;4:670–8.
Palmer JR. Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med. 1994;39:155–62.
Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol. 2010;203:531–9. https://doi.org/10.1016/j.ajog.2010.06.073.
La Vecchia C, Parazzini F, Decarli A, Franceschi S, Fasoli M, Favalli G, Negri E, Pampallona S. Age of parents and risk of gestational trophoblastic disease. J Natl Cancer Inst. 1984;73:639–42.
Sebire NJ, Foskett M, Fisher RA, Rees H, Seckl M, Newlands E. Risk of partial and complete hydatidiform molar pregnancy in relation to maternal age. BJOG. 2002;109:99–102.
Matsuura J, Chiu D, Jacobs PA, Szulman AE. Complete hydatidiform mole in Hawaii: an epidemiological study. Genet Epidemiol. 1984;1:271–84. https://doi.org/10.1002/gepi.1370010306.
Martin PM. High frequency of hydatidiform mole in native Alaskans. Int J Gynaecol Obstet. 1978;15:395–6.
Cheung A. Gestational trophoblastic diseases. In: Ho F, Wu P, editors. Topics in pathology for Hong Kong. Hong Kong: Hong Kong University Press; 1995. p. 147–63.
Martin BH, Kim JH. Changes in gestational trophoblastic tumors over four decades. A Korean experience. J Reprod Med. 1998;43:60–8.
Kajii T, Ohama K. Androgenetic origin of hydatidiform mole. Nature. 1977;268:633–4.
Lawler SD, Povey S, Fisher RA, Pickthall VJ. Genetic studies on hydatidiform moles. II. The origin of complete moles. Ann Hum Genet. 1982;46:209–22.
Paradinas FJ, Browne P, Fisher RA, Foskett M, Bagshawe KD, Newlands E. A clinical, histopathological and flow cytometric study of 149 complete moles, 146 partial moles and 107 non-molar hydropic abortions. Histopathology. 1996;28:101–10.
Szulman AE. Syndromes of hydatidiform moles. Partial vs. complete. J Reprod Med. 1984;29:788–91.
Garner EI, Goldstein DP, Feltmate CM, Berkowitz RS. Gestational trophoblastic disease. Clin Obstet Gynecol. 2007;50:112–22. https://doi.org/10.1097/GRF.0b013e31802f17fc.
Fowler DJ, Lindsay I, Seckl MJ, Sebire NJ. Histomorphometric features of hydatidiform moles in early pregnancy: relationship to detectability by ultrasound examination. Ultrasound Obstet Gynecol. 2007;29:76–80. https://doi.org/10.1002/uog.3880.
Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med. 1996;335:1740–8. https://doi.org/10.1056/NEJM199612053352306.
Berkowitz RS, Goldstein DP. Clinical practice. Molar pregnancy. N Engl J Med. 2009;360:1639–45. https://doi.org/10.1056/NEJMcp0900696.
Baergen RN, Kelly T, McGinniss MJ, Jones OW, Benirschke K. Complete hydatidiform mole with a coexistent embryo. Hum Pathol. 1996;27:731–4.
Keep D, Zaragoza MV, Hassold T, Redline RW. Very early complete hydatidiform mole. Hum Pathol. 1996;27:708–13.
Sebire NJ, Fisher RA, Rees HC. Histopathological diagnosis of partial and complete hydatidiform mole in the first trimester of pregnancy. Pediatr Dev Pathol. 2003;6:69–77. https://doi.org/10.1007/s10024-002-0079-9.
Kim KR, Park BH, Hong YO, Kwon HC, Robboy SJ. The villous stromal constituents of complete hydatidiform mole differ histologically in very early pregnancy from the normally developing placenta. Am J Surg Pathol. 2009;33:176–85. https://doi.org/10.1097/PAS.0b013e31817fada1.
Kim MJ, Kim KR, Ro JY, Lage JM, Lee HI. Diagnostic and pathogenetic significance of increased stromal apoptosis and incomplete vasculogenesis in complete hydatidiform moles in very early pregnancy periods. Am J Surg Pathol. 2006;30:362–9. https://doi.org/10.1097/01.pas.0000194299.27463.21.
LeGallo RD, Stelow EB, Ramirez NC, Atkins KA. Diagnosis of hydatidiform moles using p57 immunohistochemistry and HER2 fluorescent in situ hybridization. Am J Clin Pathol. 2008;129:749–55. https://doi.org/10.1309/7XRL378C22W7APBT.
McConnell TG, Murphy KM, Hafez M, Vang R, Ronnett BM. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. Am J Surg Pathol. 2009;33:805–17. https://doi.org/10.1097/PAS.0b013e318191f309.
Banet N, DeScipio C, Murphy KM, Beierl K, Adams E, Vang R, Ronnett BM. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping. Mod Pathol. 2014;27:238–54. https://doi.org/10.1038/modpathol.2013.143.
Lewis GH, DeScipio C, Murphy KM, Haley L, Beierl K, Mosier S, Tandy S, Cohen DS, Lytwyn A, Elit L, Vang R, Ronnett BM. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease. Int J Gynecol Pathol. 2013;32:199–214. https://doi.org/10.1097/PGP.0b013e3182630d8c.
Ronnett BM, DeScipio C, Murphy KM. Hydatidiform moles: ancillary techniques to refine diagnosis. Int J Gynecol Pathol. 2011;30:101–16. https://doi.org/10.1097/PGP.0b013e3181f4de77.
Siu MK, Wong ES, Chan HY, Ngan HY, Chan KY, Cheung AN. Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Am J Pathol. 2008;173:1165–72. https://doi.org/10.2353/ajpath.2008.080288.
Shih Ie M, Kuo KT. Power of the eternal youth: Nanog expression in the gestational choriocarcinoma. Am J Pathol. 2008;173:911–4. https://doi.org/10.2353/ajpath.2008.080624.
Chiu PM, Liu VW, Ngan HY, Khoo US, Cheung AN. Detection of mitochondrial DNA mutations in gestational trophoblastic disease. Hum Mutat. 2003;22:177. https://doi.org/10.1002/humu.9160.
Murphy KM, Descipio C, Wagenfuehr J, Tandy S, Mabray J, Beierl K, Micetich K, Libby AL, Ronnett BM. Tetraploid partial hydatidiform mole: a case report and review of the literature. Int J Gynecol Pathol. 2012;31:73–9. https://doi.org/10.1097/PGP.0b013e31822555b3.
Lipata F, Parkash V, Talmor M, Bell S, Chen S, Maric V, Hui P. Precise DNA genotyping diagnosis of hydatidiform mole. Obstet Gynecol. 2010;115:784–94. https://doi.org/10.1097/AOG.0b013e3181d489ec.
Fukunaga M, Endo Y, Ushigome S. Clinicopathologic study of tetraploid hydropic villous tissues. Arch Pathol Lab Med. 1996;120:569–72.
Brown L, Mount S, Reddy R, Slim R, Wong C, Jobanputra V, Clifford P, Merrill L, Brown S. Recurrent pregnancy loss in a woman with NLRP7 mutation: not all molar pregnancies can be easily classified as either “partial” or “complete” hydatidiform moles. Int J Gynecol Pathol. 2013;32:399–405. https://doi.org/10.1097/PGP.0b013e31826cbf6a.
Nguyen NM, Slim R. Genetics and epigenetics of recurrent hydatidiform moles: basic science and genetic counselling. Curr Obstet Gynecol Rep. 2014;3:55–64. https://doi.org/10.1007/s13669-013-0076-1.
Nguyen NM, Zhang L, Reddy R, Dery C, Arseneau J, Cheung A, Surti U, Hoffner L, Seoud M, Zaatari G, Bagga R, Srinivasan R, Coullin P, Ao A, Slim R. Comprehensive genotype-phenotype correlations between NLRP7 mutations and the balance between embryonic tissue differentiation and trophoblastic proliferation. J Med Genet. 2014;51:623–34. https://doi.org/10.1136/jmedgenet-2014-102546.
Nguyen N, Khawajkie Y, Mechtouf N, Sauthier P, Arseneau J, Rahimi K, Breguet M and Slim R (2017) The genetics of recurrent hydatidiform moles: new findings and lessons from the analysis of 111 patients. XIX Biannual World Congress, International Society of Study of Trophoblastic Diseases, Amsterdam.
Buza N, Hui P. Partial hydatidiform mole: histologic parameters in correlation with DNA genotyping. Int J Gynecol Pathol. 2013;32:307–15. https://doi.org/10.1097/PGP.0b013e3182626011.
Chew SH, Perlman EJ, Williams R, Kurman RJ, Ronnett BM. Morphology and DNA content analysis in the evaluation of first trimester placentas for partial hydatidiform mole (PHM). Hum Pathol. 2000;31:914–24. https://doi.org/10.1053/hupa.2000.9085.
Sebire NJ, May PC, Kaur B, Seckl MJ, Fisher RA. Abnormal villous morphology mimicking a hydatidiform mole associated with paternal trisomy of chromosomes 3,7,8 and unipaternal disomy of chromosome 11. Diagn Pathol. 2016;11:20. https://doi.org/10.1186/s13000-016-0471-9.
Genest DR. Partial hydatidiform mole: clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis. Int J Gynecol Pathol. 2001;20:315–22.
Paradinas FJ, Sebire NJ, Fisher RA, Rees HC, Foskett M, Seckl MJ, Newlands ES. Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles. Histopathology. 2001;39:447–54.
Niemann I, Petersen LK, Hansen ES, Sunde L. Predictors of low risk of persistent trophoblastic disease in molar pregnancies. Obstet Gynecol. 2006;107:1006–11. https://doi.org/10.1097/01.AOG.0000210635.24543.3b.
Yeung C-W, Cheung ANY. Negative pregnancy test in patients with trophoblastic diseases. Curr Obstet Gynecol Rep. 2014;3:102–6. https://doi.org/10.1007/s13669-013-0067-2.
Baasanjav B, Usui H, Kihara M, Kaku H, Nakada E, Tate S, Mitsuhashi A, Matsui H, Shozu M. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles. Hum Reprod. 2010;25:1183–91. https://doi.org/10.1093/humrep/deq052.
Matsui H, Iizuka Y, Sekiya S. Incidence of invasive mole and choriocarcinoma following partial hydatidiform mole. Int J Gynaecol Obstet. 1996;53:63–4.
Agarwal R, Teoh S, Short D, Harvey R, Savage PM, Seckl MJ. Chemotherapy and human chorionic gonadotropin concentrations 6 months after uterine evacuation of molar pregnancy: a retrospective cohort study. Lancet. 2012;379:130–5. https://doi.org/10.1016/s0140-6736(11)61265-8.
Cheung AN, Chan KK. Perplexing hCG profile after evacuation of hydatidiform mole. Lancet. 2012;379:98–100. https://doi.org/10.1016/s0140-6736(11)61518-3.
Garrett LA, Garner EI, Feltmate CM, Goldstein DP, Berkowitz RS. Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia. J Reprod Med. 2008;53:481–6.
Sebire NJ, Fisher RA, Foskett M, Rees H, Seckl MJ, Newlands ES. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG. 2003;110:22–6.
Hui P, Martel M, Parkash V. Gestational trophoblastic diseases: recent advances in histopathologic diagnosis and related genetic aspects. Adv Anat Pathol. 2005;12:116–25.
Lawler SD, Fisher RA, Pickthall VJ, Povey S, Evans MW. Genetic studies on hydatidiform moles. I. The origin of partial moles. Cancer Genet Cytogenet. 1982;5:309–20.
Jauniaux E. Partial moles: from postnatal to prenatal diagnosis. Placenta. 1999;20:379–88. https://doi.org/10.1053/plac.1999.0390.
Fine C, Bundy AL, Berkowitz RS, Boswell SB, Berezin AF, Doubilet PM. Sonographic diagnosis of partial hydatidiform mole. Obstet Gynecol. 1989;73:414–8.
Jacobs PA, Szulman AE, Funkhouser J, Matsuura JS, Wilson CC. Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole. Ann Hum Genet. 1982;46:223–31.
Sundvall L, Lund H, Niemann I, Jensen UB, Bolund L, Sunde L. Tetraploidy in hydatidiform moles. Hum Reprod. 2013;28:2010–20. https://doi.org/10.1093/humrep/det132.
Golubovsky MD. Postzygotic diploidization of triploids as a source of unusual cases of mosaicism, chimerism and twinning. Hum Reprod. 2003;18:236–42.
Schammel DP, Bocklage T. p53 PCNA, and Ki-67 in hydropic molar and nonmolar placentas: an immunohistochemical study. Int J Gynecol Pathol. 1996;15:158–66.
Bifulco C, Johnson C, Hao L, Kermalli H, Bell S, Hui P. Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis. Am J Surg Pathol. 2008;32:445–51. https://doi.org/10.1097/PAS.0b013e3181520034.
DeScipio C, Haley L, Beierl K, Pandit AP, Murphy KM, Ronnett BM. Diandric triploid hydatidiform mole with loss of maternal chromosome 11. Am J Surg Pathol. 2011;35:1586–91. https://doi.org/10.1097/PAS.0b013e31822d5cff.
Rice LW, Berkowitz RS, Lage JM, Goldstein DP, Bernstein MR. Persistent gestational trophoblastic tumor after partial hydatidiform mole. Gynecol Oncol. 1990;36:358–62.
Hancock BW, Nazir K, Everard JE. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome. J Reprod Med. 2006;51:764–6.
Seckl MJ, Fisher RA, Salerno G, Rees H, Paradinas FJ, Foskett M, Newlands ES. Choriocarcinoma and partial hydatidiform moles. Lancet. 2000;356:36–9. https://doi.org/10.1016/S0140-6736(00)02432-6.
Bynum J, Murphy KM, DeScipio C, Beierl K, Adams E, Anderson D, Vang R, Ronnett BM. Invasive complete hydatidiform moles: analysis of a case series with genotyping. Int J Gynecol Pathol. 2016;35:134–41. https://doi.org/10.1097/PGP.0000000000000232.
Gaber LW, Redline RW, Mostoufi-Zadeh M, Driscoll SG. Invasive partial mole. Am J Clin Pathol. 1986;85:722–4.
Fukunaga M, Katabuchi H, Nagasaka T, Mikami Y, Minamiguchi S, Lage JM. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol. 2005;29:942–7.
Ober WB, Edgcomb JH, Price EB Jr. The pathology of choriocarcinoma. Ann N Y Acad Sci. 1971;172:299–426.
Llewellyn-Jones D. Trophoblastic tumors; geographical variations in incidence and possible aetiological factors. J Obstet Gynaecol Br Commonw. 1965;72:242–8.
Shanmugaratnam K, Muir CS, Tow SH, Cheng WC, Christine B, Pedersen E. Rates per 100,000 births and incidence of choriocarcinoma and malignant mole in Singapore Chinese and Malays. Comparison with Connecticut, Norway and Sweden. Int J Cancer. 1971;8:165–75.
Nakano R, Sasaki K, Yamoto M, Hata H. Trophoblastic disease: analysis of 342 patients. Gynecol Obstet Investig. 1980;11:237–42.
Poen HT, Djojopranoto M. The possible etiologic factors of hydatidiform mole and choriocarcinoma: preliminary report. Am J Obstet Gynecol. 1965;92:510–3.
Brinton LA, Bracken MB, Connelly RR. Choriocarcinoma incidence in the United States. Am J Epidemiol. 1986;123:1094–100.
Ringertz N. Hydatidiform mole, invasive mole and choriocarcinoma in Sweden 1958–1965. Acta Obstet Gynecol Scand. 1970;49:195–203.
Smith HO. Gestational trophoblastic disease epidemiology and trends. Clin Obstet Gynecol. 2003;46:541–56.
Soper JT. Gestational trophoblastic disease. Obstet Gynecol. 2006;108:176–87. https://doi.org/10.1097/01.AOG.0000224697.31138.a1.
Smith HO, Kohorn E, Cole LA. Choriocarcinoma and gestational trophoblastic disease. Obstet Gynecol Clin N Am. 2005;32:661–84. https://doi.org/10.1016/j.ogc.2005.08.001.
Lurain JR, Brewer JI, Torok EE, Halpern B. Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol. 1983;145:591–5.
Bagshawe KD, Golding PR, Orr AH. Choriocarcinoma after hydatidiform mole. Studies related to effectiveness of follow-up practice after hydatidiform mole. Br Med J. 1969;3:733–7.
Jacques SM, Qureshi F, Doss BJ, Munkarah A. Intraplacental choriocarcinoma associated with viable pregnancy: pathologic features and implications for the mother and infant. Pediatr Dev Pathol. 1998;1:380–7.
Sebire NJ, Lindsay I, Fisher RA, Seckl MJ. Intraplacental choriocarcinoma: experience from a tertiary referral center and relationship with infantile choriocarcinoma. Fetal Pediatr Pathol. 2005;24:21–9.
Fu Y, Lu W, Zhou C, Xie X. Primary cervical choriocarcinoma: report of four cases and literature review. Int J Gynecol Cancer. 2007;17:715–9. https://doi.org/10.1111/j.1525-1438.2007.00819.x.
Chan DP, Wong WP. Extrauterine gestational choriocarcinoma. Report of two cases. Obstet Gynecol. 1970;35:730–3.
Ober WB, Maier RC. Gestational choriocarcinoma of the fallopian tube. Diagn Gynecol Obstet. 1981;3:213–31.
Mazur MT. Metastatic gestational choriocarcinoma. Unusual pathologic variant following therapy. Cancer. 1989;63:1370–7.
Shen DH, Khoo US, Ngan HY, Ng TY, Chau MT, Xue WC, Cheung AN. Coexisting epithelioid trophoblastic tumor and choriocarcinoma of the uterus following a chemoresistant hydatidiform mole. Arch Pathol Lab Med. 2003;127:e291–3. https://doi.org/10.1043/1543-2165(2003)127<e291:CETTAC>2.0.CO;2.
Kalhor N, Ramirez PT, Deavers MT, Malpica A, Silva EG. Immunohistochemical studies of trophoblastic tumors. Am J Surg Pathol. 2009;33:633–8. https://doi.org/10.1097/PAS.0b013e318191f2eb.
Mao TL, Kurman RJ, Huang CC, Lin MC, Shih Ie M. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis. Am J Surg Pathol. 2007;31:1726–32. https://doi.org/10.1097/PAS.0b013e318058a529.
Shih IM, Kurman RJ. Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies. Hum Pathol. 1998;29:27–33.
Shih IM, Kurman RJ. Immunohistochemical localization of inhibin-alpha in the placenta and gestational trophoblastic lesions. Int J Gynecol Pathol. 1999;18:144–50.
Yap KL, Hafez MJ, Mao TL, Kurman RJ, Murphy KM, Shih Ie M. Lack of a y-chromosomal complement in the majority of gestational trophoblastic neoplasms. J Oncol. 2010;2010:364508. https://doi.org/10.1155/2010/364508.
Rodriguez E, Melamed J, Reuter V, Chaganti RS. Chromosomal abnormalities in choriocarcinomas of the female. Cancer Genet Cytogenet. 1995;80:9–12.
Sheppard DM, Fisher RA, Lawler SD. Karyotypic analysis and chromosome polymorphisms in four choriocarcinoma cell lines. Cancer Genet Cytogenet. 1985;16:251–8.
Savage J, Adams E, Veras E, Murphy KM, Ronnett BM. Choriocarcinoma in women: analysis of a case series with genotyping. Am J Surg Pathol. 2017;41:1593–606. https://doi.org/10.1097/pas.0000000000000937.
Cheung AN, Zhang HJ, Xue WC, Siu MK. Pathogenesis of choriocarcinoma: clinical, genetic and stem cell perspectives. Future Oncol. 2009;5:217–31. https://doi.org/10.2217/14796694.5.2.217.
Morgan JM, Lurain JR. Gestational trophoblastic neoplasia: an update. Curr Oncol Rep. 2008;10:497–504.
Rodabaugh KJ, Bernstein MR, Goldstein DP, Berkowitz RS. Natural history of postterm choriocarcinoma. J Reprod Med. 1998;43:75–80.
Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment. Int J Gynecol Cancer. 2001;11:73–7.
Baergen RN, Rutgers JL, Young RH, Osann K, Scully RE. Placental site trophoblastic tumor: a study of 55 cases and review of the literature emphasizing factors of prognostic significance. Gynecol Oncol. 2006;100:511–20. https://doi.org/10.1016/j.ygyno.2005.08.058.
Hassadia A, Gillespie A, Tidy J, Everard RGNJ, Wells M, Coleman R, Hancock B. Placental site trophoblastic tumour: clinical features and management. Gynecol Oncol. 2005;99:603–7. https://doi.org/10.1016/j.ygyno.2005.06.054.
Chang YL, Chang TC, Hsueh S, Huang KG, Wang PN, Liu HP, Soong YK. Prognostic factors and treatment for placental site trophoblastic tumor-report of 3 cases and analysis of 88 cases. Gynecol Oncol. 1999;73:216–22. https://doi.org/10.1006/gyno.1999.5344.
Scully RE, Young RH. Trophoblastic pseudotumor: a reappraisal. Am J Surg Pathol. 1981;5:75–6.
Young RH, Scully RE. Placental-site trophoblastic tumor: current status. Clin Obstet Gynecol. 1984;27:248–58.
Young RH, Scully RE, McCluskey RT. A distinctive glomerular lesion complicating placental site trophoblastic tumor: report of two cases. Hum Pathol. 1985;16:35–42.
Mazzucco G, Colla L, Monga G. Kidney involvement in a patient affected by placental site trophoblastic tumor. Am J Kidney Dis. 2011;57:516–20. https://doi.org/10.1053/j.ajkd.2010.11.019.
Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol. 2001;20:31–47.
Hui P, Wang HL, Chu P, Yang B, Huang J, Baergen RN, Sklar J, Yang XJ, Soslow RA. Absence of Y chromosome in human placental site trophoblastic tumor. Mod Pathol. 2007;20:1055–60. https://doi.org/10.1038/modpathol.3800941.
Hui P, Riba A, Pejovic T, Johnson T, Baergen RN, Ward D. Comparative genomic hybridization study of placental site trophoblastic tumour: a report of four cases. Mod Pathol. 2004;17:248–51. https://doi.org/10.1038/modpathol.3800025.
Hui P, Parkash V, Perkins AS, Carcangiu ML. Pathogenesis of placental site trophoblastic tumor may require the presence of a paternally derived X chromosome. Lab Investig. 2000;80:965–72.
Xue WC, Guan XY, Ngan HY, Shen DH, Khoo US, Cheung AN. Malignant placental site trophoblastic tumor: a cytogenetic study using comparative genomic hybridization and chromosome in situ hybridization. Cancer. 2002;94:2288–94. https://doi.org/10.1002/cncr.10424.
Feltmate CM, Genest DR, Wise L, Bernstein MR, Goldstein DP, Berkowitz RS. Placental site trophoblastic tumor: a 17-year experience at the New England Trophoblastic Disease Center. Gynecol Oncol. 2001;82:415–9. https://doi.org/10.1006/gyno.2001.6265.
Papadopoulos AJ, Foskett M, Seckl MJ, McNeish I, Paradinas FJ, Rees H, Newlands ES. Twenty-five years’ clinical experience with placental site trophoblastic tumors. J Reprod Med. 2002;47:460–4.
Finkler NJ. Placental site trophoblastic tumor. Diagnosis, clinical behavior and treatment. J Reprod Med. 1991;36:27–30.
Schmid P, Nagai Y, Agarwal R, Hancock B, Savage PM, Sebire NJ, Lindsay I, Wells M, Fisher RA, Short D, Newlands ES, Wischnewsky MB, Seckl MJ. Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study. Lancet. 2009;374:48–55. https://doi.org/10.1016/S0140-6736(09)60618-8.
Fadare O, Parkash V, Carcangiu ML, Hui P. Epithelioid trophoblastic tumor: clinicopathological features with an emphasis on uterine cervical involvement. Mod Pathol. 2006;19:75–82. https://doi.org/10.1038/modpathol.3800485.
Hamazaki S, Nakamoto S, Okino T, Tsukayama C, Mori M, Taguchi K, Okada S. Epithelioid trophoblastic tumor: morphological and immunohistochemical study of three lung lesions. Hum Pathol. 1999;30:1321–7.
Kuo KT, Chen MJ, Lin MC. Epithelioid trophoblastic tumor of the broad ligament: a case report and review of the literature. Am J Surg Pathol. 2004;28:405–9.
Shih IM, Kurman RJ. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol. 1998;22:1393–403.
Palmer JE, Macdonald M, Wells M, Hancock BW, Tidy JA. Epithelioid trophoblastic tumor: a review of the literature. J Reprod Med. 2008;53:465–75.
Meydanli MM, Kucukali T, Usubutun A, Ataoglu O, Kafkasli A. Epithelioid trophoblastic tumor of the endocervix: a case report. Gynecol Oncol. 2002;87:219–24.
Cheung AN. Pathology of gestational trophoblastic diseases. Best Pract Res Clin Obstet Gynaecol. 2003;17:849–68.
Mao TL, Seidman JD, Kurman RJ, Shih Ie M. Cyclin E and p16 immunoreactivity in epithelioid trophoblastic tumor—an aid in differential diagnosis. Am J Surg Pathol. 2006;30:1105–10. https://doi.org/10.1097/01.pas.0000209854.28282.87.
Shih IM, Kurman RJ. p63 expression is useful in the distinction of epithelioid trophoblastic and placental site trophoblastic tumors by profiling trophoblastic subpopulations. Am J Surg Pathol. 2004;28:1177–83.
Xu ML, Yang B, Carcangiu ML, Hui P. Epithelioid trophoblastic tumor: comparative genomic hybridization and diagnostic DNA genotyping. Mod Pathol. 2009;22:232–8. https://doi.org/10.1038/modpathol.2008.165.
Tsai HW, Lin CP, Chou CY, Li CF, Chow NH, Shih IM, Ho CL. Placental site nodule transformed into a malignant epithelioid trophoblastic tumour with pelvic lymph node and lung metastasis. Histopathology. 2008;53:601–4. https://doi.org/10.1111/j.1365-2559.2008.03145.x.
Lewin SN, Aghajanian C, Moreira AL, Soslow RA. Extrauterine epithelioid trophoblastic tumors presenting as primary lung carcinomas: morphologic and immunohistochemical features to resolve a diagnostic dilemma. Am J Surg Pathol. 2009;33:1809–14. https://doi.org/10.1097/PAS.0b013e3181b9cd67.
Narita F, Takeuchi K, Hamana S, Ohbayashi C, Ayata M, Maruo T. Epithelioid trophoblastic tumor (ETT) initially interpreted as cervical cancer. Int J Gynecol Cancer. 2003;13:551–4.
Deavers MT, Kalhor N, Silva EG. Diagnostic problems with trophoblastic lesions. Arch Pathol Lab Med. 2008;132:168–74. https://doi.org/10.1043/1543-2165(2008)132[168:DPWTL]2.0.CO;2.
Lurain JR. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol. 2011;204:11–8. https://doi.org/10.1016/j.ajog.2010.06.072.
Young RH, Kurman RJ, Scully RE. Proliferations and tumors of intermediate trophoblast of the placental site. Semin Diagn Pathol. 1988;5:223–37.
Wan SK, Lam PW, Pau MY, Chan JK. Multiclefted nuclei. A helpful feature for identification of intermediate trophoblastic cells in uterine curetting specimens. Am J Surg Pathol. 1992;16:1226–32.
Yeh IT, O'Connor DM, Kurman RJ. Intermediate trophoblast: further immunocytochemical characterization. Mod Pathol. 1990;3:282–7.
Dotto J, Hui P. Lack of genetic association between exaggerated placental site reaction and placental site trophoblastic tumor. Int J Gynecol Pathol. 2008;27:562–7. https://doi.org/10.1097/PGP.0b013e31816d1d00.
Young RH, Kurman RJ, Scully RE. Placental site nodules and plaques. A clinicopathologic analysis of 20 cases. Am J Surg Pathol. 1990;14:1001–9.
Huettner PC, Gersell DJ. Placental site nodule: a clinicopathologic study of 38 cases. Int J Gynecol Pathol. 1994;13:191–8.
Shih IM, Seidman JD, Kurman RJ. Placental site nodule and characterization of distinctive types of intermediate trophoblast. Hum Pathol. 1999;30:687–94.
Shitabata PK, Rutgers JL. The placental site nodule: an immunohistochemical study. Hum Pathol. 1994;25:1295–301.
Chen BJ, Cheng CJ, Chen WY. Transformation of a post-cesarean section placental site nodule into a coexisting epithelioid trophoblastic tumor and placental site trophoblastic tumor: a case report. Diagn Pathol. 2013;8:85. https://doi.org/10.1186/1746-1596-8-85.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Science Press & Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ip, P.P.C., Wang, Y., Cheung, A.N.Y. (2019). Complications of Early Pregnancy and Gestational Trophoblastic Diseases. In: Zheng, W., Fadare, O., Quick, C., Shen, D., Guo, D. (eds) Gynecologic and Obstetric Pathology, Volume 2. Springer, Singapore. https://doi.org/10.1007/978-981-13-3019-3_13
Download citation
DOI: https://doi.org/10.1007/978-981-13-3019-3_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3018-6
Online ISBN: 978-981-13-3019-3
eBook Packages: MedicineMedicine (R0)